Document is current

Article History

Received: 22 July 2024

Revised: 2 October 2024

Accepted: 5 October 2024

First Online: 12 December 2024

Declarations

:

: SJT reports research funding from AbbVie, Aeon, Amgen, Annovis, Axsome, Cassava, Cognition, Eli Lilly, Inhibikase, Ipsen, Lundbeck, Merz, Neurolief, Pfizer, PrecisionMed, Revance, Scilex, Suven, and UCB. He served as a consultant and/or on advisory boards (honoraria) from AbbVie, Aeon, Alphasights, Amgen, Aruene/eNeura, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, ClearView Healthcare Partners, ClickTherapeutics, CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Initiator Pharma, InteractiveForums, Keyquest, Ki Health Partners, Krog and Partners, Lundbeck, M3 Global Research, Magellan Health, Magnolia Innovation, Miravo Healthcare, MJH Holdings, Neurofront Therapeutics, Neurolief, Nocira, Novartis, P Value Communications, Pain Insights, Palion Medical, Perfood, Pfizer, Pulmatrix, Putnam Associates, Rehaler, SAI MedPartners, Satsuma, Scilex, Slingshot Insights, Spherix Global Insights, Strategy Inc, Synapse Medical Communication, System Analytic, Taylor and Francis, Tegus, Teva, Theranica, Tonix, Trinity Partners, Unity HA, Vial, and XOC. He received salary from Dartmouth-Hitchcock Medical Center, Thomas Jefferson University, and Ki Health Partners. He serves on the speakers' bureau for AbbVie, Eli Lilly, Pfizer, Scilex, and Teva. He received CME honoraria from the American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket Medical Education, HMP Global, Medical Education Speakers Network, Medical Learning Institute Peerview, Migraine Association of Ireland, Miller Medical Education, National Association for Continuing Education, North American Center for CME, The Ohio State University, Physicians’ Education Resource, PlatformQ Education, Primed, Vindico Medical Education, and WebMD/Medscape. MLD is an advisory board member for Amgen, Assertio, Eli Lilly, Lundbeck, Promius Pharma, Supernus Pharmaceuticals, Teva, and Upsher‐Smith Laboratories; a consultant for Amgen, Eli Lilly, Lundbeck, Promius Pharma, and Teva; and speaker's bureau for Amgen, Assertio, Eli Lilly, Supernus Pharmaceuticals, and Teva. DA and DF are full-time employees of Lundbeck LLC. JH is an employee of Pacific Northwest Statistical Consulting, Inc., a company that received funding from Lundbeck LLC for time spent conducting this research. RC was an employee of Lundbeck LLC for the development and conduct of PROMISE-2 and currently consults with Lundbeck and is a part time employee at Axon.

: This study was approved by the independent ethics committee or institutional review board at each study site. All clinical work was conducted in compliance with current good clinical practices, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use guidelines, local regulatory requirements, and the principles of the Declaration of Helsinki.

: All patients enrolled in the study provided written informed consent before any study procedures.